Dutch enforcer probes drugmakers over excessive pricing and tying

The Dutch competition authority has launched a preliminary investigation to determine if three pharmaceutical companies are tying their services and charging excessive prices to both healthcare and insurance providers.

Unlock unlimited access to all Global Competition Review content